Naga Chalasani, M.D.
June 21, 2012
Welcome to the website of IU Division of Gastroenterology and Hepatology. Our division has a distinguished tradition of excellence in patient care and innovation in research and education. Consistently ranked in the top 15 units nationally by US News and World Report, we are one of the largest divisions in the country with enormous breadth to our clinical and research expertise. Our division, founded by Dr. Philip Christiansen in 1958, has flourished over the last two decades under the leadership of Drs. Lawrence Lumeng (Division Director from 1984 to 2007) and Glen Lehman (Clinical Director from 1985- 2005). Under the current leadership, there has been significant growth to our faculty and fellowship size, patient and procedural volume, and our federally funded research program. To better withstand unfolding challenges of our health care system, we have joined Indiana University Health Physicians (IUHP) as its Digestive and Liver Disorders service line in October 2011.
Our administrative offices are located on the fourth floor of the Regenstrief Building. Our home base is in downtown Indianapolis where we are the exclusive GI and hepatology care providers at Indiana University Hospital, Wishard Memorial Hospital, and the Richard L. Roudebush VA Medical Center. In order to better serve our suburban patients, we also have an office and a procedure suite at 103rd and Spring Mill Road. Starting in July 2012, we will be providing consultative and procedural GI services at IUH-North hospital in Carmel and IUH-Saxony in Noblesville. In continuing the tradition started nearly 30 years ago, we have a robust outreach clinical program where our faculty clinicians have established practices in the towns surrounding Indianapolis. We have outreach programs at Batesville, Greensburg, Martinsville, Greenfield, Lebanon, and Zionsville. As you browse through our website, you will take notice of the breadth of our expertise in endoscopic procedures and clinical care of patients with gastrointestinal and liver illnesses.
Some highlights of our clinical strengths and expertise:
- We consistently perform more endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS) procedures than any other GI program in the United States. Our faculty physicians are pioneers in the field and have developed many of the techniques utilized for these procedures
- Our liver transplant and small bowel transplant programs are one of the largest in the country with excellent patient outcomes
- Spearheaded by Dr. Doug Rex, our colorectal cancer screening program is one of the most experienced and innovative programs in the country
- Our hepatitis C program is the most experienced and innovative in the midwest, and its leader, Dr. Paul Kwo, is an internationally recognized authority in the field
- Led by Dr. John Wo, our GI motility program is one of the largest and most comprehensive programs in the Midwest United States. Our GI motility laboratory performs high resolution esophageal impedance, Bravo esophageal pH wireless monitoring, transnasal pH and impedance monitoring (for laryngeal symptoms), High resolution anorectal manometry with rectal compliance/sensation, Antroduodenal manometry (for nausea and vomiting of unknown etiology), Hydrogen and Methane breath test, SmartPill wireless whole gut transit/motility capsule, Electrogastrography (EGG), Gastric stimulator check, Capsule endoscopy, and Secretin stimulation test for acid hypersecretion
- We are the only group in the State of Indiana with dedicated expertise in inflammatory bowel disease (Crohn's disease and ulcerative colitis) and celiac disease
- For treatment of precancerous and early stage cancers of the gastrointestinal tract, we offer all advanced luminal endoscopic procedures including endoscopic mucosal resection, photodynamic therapy, radiofrequency ablation, argon plasma coagulation, luminal stenting, polypectomy of small and large polyps
- We are one of the top programs nationally and the only center in Indiana for performing double balloon enteroscopy
- We are the only GI group in entire Indiana to have two full time GI psychologists on faculty
- We are the only GI group in entire Indiana to have a bariatric physician on staff to medically manage obesity
- We are the only center in Indiana to pioneer cutting edge technologies such as the use of mini scopes to investigate diseases of the pancreas and biliary tree, lithotripsy of pancreatic stones. natural orifice transgastric endoluminal surgery (NOTES), and anti-reflux procedures
Our research is extensive and is both laboratory-based and patient-oriented. Our group receives more than 5 million dollars of research funding each year from the National Institutes of Health and other extramural sources. We have many faculty members with sustained federal funding (both NIH and VA) and we publish more than 100 full length papers each year in top-tier medical journals. Our faculty members serve as editors and members of the editorial boards of many prestigious biomedical journals. We have faculty members who serve on NIH and VA study sections, NIAAA advisory council, and on the boards of many other national and international research organizations. Some examples of our research themes include hepatitis C, nonalcoholic fatty liver disease, drug hepatotoxicity, alcoholic liver disease, colorectal cancer screening, new endoscopic devices and techniques including those to treat acid reflux, minimally invasive endoscopic techniques to treat precancerous and early cancers of the gastrointestinal tract, pancreas and biliary tree, endoscopic treatment of a variety of diseases of the biliary tree and pancreas, endoscopic sedation, sphincter of oddi dysfunction, and cystic tumors of pancreas.
Education and mentoring are critical to our mission. We host one of the most robust general GI and advanced therapeutic endoscopy fellowships in the country and we will be starting a dedicated advanced IBD fellowship in July 2012. We are very proud that many of the prominent gastroenterologist's practicing in central Indiana are our former trainees (to name a few, Drs, Greg Blitz, Brian Sipes, Arthur Baluyut, Matt Harrison, Chris Sofianos, Mike Hartley, Paul Haynes, David Pound, Ernest Orinion, Dan Ciaccia, Frank Troiano, Michael Elmore, Spencer Wilson). Our faculty members conduct local CME programs throughout the year in the form of several ERCP and EUS courses, annual GI update course, and annual AASLD update. Many of our faculty members regularly lecture at various national and international meetings.
Whether you are a patient looking for a competent and compassionate GI physician, a medical student contemplating a GI elective, a medical resident looking for a GI fellowship, a researcher looking for a collaborator/study site, or if you are looking for a faculty position, please consider giving us a chance. We are very confident that you will not be disappointed.
Naga Chalasani, MD, FACG
Professor of Medicine and Cellular & Integrative Physiology
Director, Division of Gastroenterology and Hepatology
Director, IUHP Digestive and Liver Disorders
6/3: Nicholas Shaheen, MD: "Evolving Concepts in Barrett's Esophagus".
6/10: Toyia James-Stevenson, MD: "Antidepressants in Functional Bowel Disease".
Dr. David Crabb and Dr. Naga Chalasani: NIAAA U01 Award: "Translational Research and Evolving Alcoholic hepatitis Treatment (TREAT consortium)". 5-year Grant, IU total cost $5,008,254 (direct $3,210,421; indirect $1,797,833).
Dr. Charles Kahi: VA Merit Review-CSR&D: Association of Colonoscopy and Colorectal Cancer Mortality in the VHA System. 3-year Grant, total cost $450,000.
IU Division of Gastroenterology and Hepatology is ranked #11 nationally according to the most recent US News and World Report (7/16/12)- IU Health is for the first time among the elite Honor Roll of Best Hospitals in the country (# 16)
Dr. Gregory Cote: NIH/NIDDK research career development Award (K23): "Optimizing the role of ERCP in evaluating indeterminate bile duct strictures." 5-year Grant, direct costs of $817,775.
Dr. Suthat Liangpunsakul: Department of Defense, research Award: "Phospholipids as biomarkers for excessive alcohol use". Grant total $1,149,601 (direct $750,000; indirect $399,601).